The CDC had a very narrow definition of who is immunocompromised: it includes people undergoing treatment for solid tumors or blood cancers; organ transplant patients, including those who have gotten a stem cell transplant within the last two years; and people with advanced or untreated HIV. Camil...
“This is an exciting and powerful moment,” she added, “It could only happen because of the work from so many who made sure we had the rapid administration of three safe and effectivevaccines.” Dr. Walensky cited three large studies on the effectiveness of COVID-19vaccinesagainst ...
For those who only need one dose for the season, vaccinating as early as July and August may result in less than optimal immunity before the season ends, especially among older adults. SUGGESTED for you For the 2019–2020 season, ACIP expects inactivated influenza vaccines (IIVs), recombinant ...
On August 6, 2024, the United States Centers for Disease Control and Prevention updated itsrecommendations for respiratory syncytial virus (RSV)vaccines in adults ages 60 and older. The updated recommendations are based on a vote from the Advisory Committee on Immunization Practices...
The news follows the FDA’s expanded emergency use of Pfizer-BioNTech and Moderna’sCOVID-19vaccinesto authorize a booster shot for certain immunocompromised patients. {{#rendered}}{{/rendered}} "This is an important step forward in improving protection against COVID-19," Dr. Gregory Poland, ...
WASHINGTON, Feb. 23 (Xinhua) -- The U.S. Centers for Disease Control and Prevention (CDC) has updated its guidance on COVID-19 mRNA vaccines, expanding the recommended time between the initial two vaccine doses to eight weeks for certain people. ...
COVID-19 vaccinesare effective at protecting you from getting sick. Vaccination is an important tool to help us get back to normal. This information will help you prepare for your COVID-19 vaccination. Learn more about the different types of COVID-19 vaccines andhow they work. ...
If followed by the target population, this recommendation will offer these individuals additional protection against the infection by compensating for the waning immunity from earlier or initial vaccine doses. “What the vaccines are doing now is providing an incremental benefit or an ex...
The CDC's move came right after the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for these people earlier Tuesday. In addition, the CDC said adults who received a primary vaccine and booster dose of Johnson...
Ahead of the rollout ofthis fall's new COVID-19 vaccines, a Centers for Disease Control and Prevention work group wrestled for months over whether shots should be recommended for all eligible Americans or only for some of the most vulnerable groups. ...